Latest Can-Fite BioPharma News & Updates

See the latest news and media coverage for Can-Fite. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Can-Fite BioPharma (Can-Fite)

Biopharmaceutical developer of oral treatments for cancer, inflammatory, metabolic diseases

canfite.com
Number of employees
5–10
Industry
Pharmaceuticals

Last updated

Latest news about Can-Fite BioPharma (Can-Fite)

In short: Can-Fite advanced its clinical pipeline, highlighted by positive pancreatic cancer data for Namodenoson and Phase 3 psoriasis progress.

Company announcements

Can-Fite

Can-Fite completes patient enrolment for Phase 3 psoriasis interim analysis

The interim analysis follows an FDA- and EMA-agreed protocol, with results expected in Q4 2026 or Q1 2027.

Unlock all announcements with a

Media coverage

Yahoo Finance

Can-Fite Achieves Key Pivotal Phase 3 Psoriasis Milestone with Completion of Patient Enrolment for the Interim Analysis: Data Expected Q4 2026/Q1 2027

Interim analysis to be conducted under an FDA- and EMA-agreed protocol Ramat Gan, Israel, July 06, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American...

Unlock all articles with a

Never miss news about Can-Fite

Track Can-Fite and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.